There’s an EpiPen Tycoon computer game. In it, you are the CEO of Mylan, Heather Bresch, the daughter of a US senator who has been handed a drug that lays a golden egg — EpiPen, an emergency anaphylaxis treatment that stops people’s throats from closing in the event of an allergic reaction. It’s mostly for children. In real life, Bresch infamously jacked up the price of the drug from around $100 in 2007 to where it now sits, at $608. This caused has caused a public outcry. In the game, you, the player, must balance making your shareholders happy — apparently they love if when you increase the price of the drug — and making sure you’re not tarred and feathered on Twitter.